Results 41 to 50 of about 74,851 (248)

Reliability of medical students' vaccination histories for immunisable diseases [PDF]

open access: yes, 2008
Background Medical students come into contact with infectious diseases early on their career. Immunity against vaccine-preventable diseases is therefore vital for both medical students and the patients with whom they come into contact.
René Gottschalk   +11 more
core   +1 more source

Vaccine-Associated Measles Encephalitis in Immunocompromised Child, California, USA

open access: yesEmerging Infectious Diseases, 2022
We report a fatal case of vaccine-associated measles encephalitis in an immunocompromised child in California, USA. The infection was confirmed by whole-genome RNA sequencing of measles virus from brain tissue.
Cristina Costales   +8 more
doaj   +1 more source

Humoral and cellular immunity to measles and rubella virus antigens in healthy subjects

open access: yesИнфекция и иммунитет, 2019
An issue of eradicating measles and rubella virus-induced infections currently remains unresolved, despite existing effective methods for specific prophylaxis and WHO’s commitment to a mass vaccination policy. While improving epidemic situation, analysis
M. A. Smerdova   +6 more
doaj   +1 more source

Measles elimination: progress, challenges and implications for rubella control.

open access: yes, 2013
Measles and rubella are major vaccine-preventable causes of child mortality and disability. They have been eliminated from the Americas and some other regions have also come close to elimination.
Lessler, Justin   +7 more
core   +1 more source

Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives

open access: yesAdvanced Science, EarlyView.
This review surveys nanoparticle‐based strategies to enhance adoptive cell therapy, particularly CAR‐T cell approaches, in solid tumor treatment. It describes how nanoparticles can improve tumor immunogenicity and T‐cell infiltration while reducing toxicity, and how they enable in vivo CAR‐T cell generation.
Erica Frostegård   +19 more
wiley   +1 more source

Key parameters of measles virus production for oncolytic virotherapy

open access: yes, 2012
Attenuated measles virus has revealed selective tumor cell killing and is currently tested in clinical trials for the therapy of cancer patients. The amount of infectious particles per dose needed for oncolytic therapy can be more than a million times ...
Salzig, Denise   +10 more
core   +1 more source

Endogenous Engineering Reprograms Extracellular Vesicles for Enhanced Therapeutic Function

open access: yesAdvanced Science, EarlyView.
This review explains how Extracellular vesicles‐producing cells can be endogenously engineered to load therapeutic proteins and nucleic acids. We summarize physiological and genetic strategies that harness native sorting pathways for selective cargo loading.
Jinghui Wang   +10 more
wiley   +1 more source

Etoposide-induced apoptosis in murine neuroblastoma (N2A) cells infected with Paramyxoviruses

open access: yesArquivo Brasileiro de Medicina Veterinária e Zootecnia, 2003
The present study aimed to determine whether measles virus can induce apoptosis in murine neuroblastoma cells and the behavior of these cells under acute infection with measles virus or persistent infection with canine distemper virus upon treatment with
L. Moro, A.C. Vasconcelos, A.S. Martins
doaj   +1 more source

External Quality Assessment for the Detection of Measles Virus by Reverse Transcription-PCR Using Armored RNA. [PDF]

open access: yesPLoS ONE, 2015
In recent years, nucleic acid tests for detection of measles virus RNA have been widely applied in laboratories belonging to the measles surveillance system of China.
Dong Zhang   +10 more
doaj   +1 more source

Atypical Clinical Course of Griscelli Syndrome Type 2 With Primarily Neurologic Presentation and Adult‐Onset in a 46‐Year‐Old Male

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Griscelli Syndrome Type 2 (GS2) is a rare autosomal recessive disorder caused by pathogenic mutations in the RAB27A gene. Typically, it is characterized by cutaneous hypopigmentation, immunodeficiency, with or without neurological abnormalities secondary to hemophagocytic lymphohistiocytosis (HLH). Without treatment, GS2 often results in fatal
Dzhoy Papingi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy